Informations: Ceci n’est pas la version la plus récente du modèle de données. Vous trouverez un aperçu de la version à gauche, sous Versions. Vous trouverez la version la plus actuelle ici.
Informations:
Erreur:
ID
23184
Description
Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using TACE With Antiangiogenesis; ODM derived from: https://clinicaltrials.gov/show/NCT00518557
Lien
https://clinicaltrials.gov/show/NCT00518557
Mots-clés
Versions (2)
- 27/06/2017 27/06/2017 -
- 20/09/2021 20/09/2021 -
Téléchargé le
27 juin 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Hepatocellular Carcinoma NCT00518557
Eligibility Hepatocellular Carcinoma NCT00518557
- StudyEvent: Eligibility
Similar models
Eligibility Hepatocellular Carcinoma NCT00518557
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
ID.1
Item
patients with cytologically or histologically documented hcc, who are candidates for tace
boolean
C2239176 (UMLS CUI [1,1])
C3539919 (UMLS CUI [1,2])
C3539919 (UMLS CUI [1,2])
ID.2
Item
child-pugh child a or b
boolean
C2347612 (UMLS CUI [1])
ID.3
Item
age >= 18
boolean
C0001779 (UMLS CUI [1])
ID.4
Item
measurable disease by recist criteria;
boolean
C1709926 (UMLS CUI [1])
ID.5
Item
performance status ecog 0-2
boolean
C1520224 (UMLS CUI [1])
ID.6
Item
previous local therapy completed > 4 weeks
boolean
C1517925 (UMLS CUI [1])
ID.7
Item
written informed consent signed
boolean
C0021430 (UMLS CUI [1])
ID.8
Item
normal organ and marrow function defined as:
boolean
C0678852 (UMLS CUI [1])
ID.10
Item
wbc ≥ 3,000/µl platelet count > 80,000/mm3
boolean
C0018957 (UMLS CUI [1,1])
C0023516 (UMLS CUI [1,2])
C0032181 (UMLS CUI [1,3])
C0023516 (UMLS CUI [1,2])
C0032181 (UMLS CUI [1,3])
ID.11
Item
haemoglobin > 9g/dl
boolean
C0019046 (UMLS CUI [1])
ID.12
Item
hepatic: albumin ≥ 2.8 g/dl. serum total bilirubin ≤ 3 mg/dl; ast or alt < 5 x uln
boolean
C0201838 (UMLS CUI [1,1])
C1278039 (UMLS CUI [1,2])
C0004002 (UMLS CUI [1,3])
C0001899 (UMLS CUI [1,4])
C1278039 (UMLS CUI [1,2])
C0004002 (UMLS CUI [1,3])
C0001899 (UMLS CUI [1,4])
ID.13
Item
renal: creatinine < 1.5 x uln
boolean
C0010294 (UMLS CUI [1])
ID.14
Item
metastases
boolean
C0027627 (UMLS CUI [1])
ID.15
Item
prior or concomitant chemotherapy or radiation therapy
boolean
C3178775 (UMLS CUI [1])
ID.16
Item
vegf/vegfr- inhibitors or other anti-angiogenesis agents
boolean
C1257849 (UMLS CUI [1])
ID.17
Item
severe and/or uncontrolled medical conditions:
boolean
C0012634 (UMLS CUI [1])
ID.18
Item
congestive heart failure, serious cardiac arrhythmia, active coronary artery
boolean
C0018799 (UMLS CUI [1])
ID.19
Item
severe renal impairment
boolean
C0022658 (UMLS CUI [1])
ID.20
Item
patients who anticipate receiving major surgery during the course of the
boolean
C0679637 (UMLS CUI [1])
ID.21
Item
pregnant or breastfeeding patients
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
C0006147 (UMLS CUI [1,2])
ID.22
Item
evidence of bleeding diathesis
boolean
C0005779 (UMLS CUI [1])